Edge Rankings

Stock Score Locked: Want to See it?

Benzinga Rankings give you vital metrics on any stock – anytime.

DBV Technologies Stock Price, Quotes and Forecasts | NASDAQ:DBVT | Benzinga

Q: What sector and industry does DBV Technologies (DBVT) operate in?

DBV Technologies is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.

Explore DBV Technologies stock price, quotes, charts and forecasts with Benzinga. Stay updated on market trends for DBVT.

Open	$7.47
Close	$7.79
Volume / Avg.	52.59K / 407.44K
Day Range	$7.33 - $7.80
52 Wk Range	2.20 - 15.57
Market Cap	$201.75M
P/E Ratio	-
Dividend Yield	-
Exchange	NASDAQ
RSI	63
Short Interest	8.87%
Days to Cover	1

Recent News

3 Biopharmaceutical Stocks Bucking the Sell-Off

With tariffs sending markets reeling in the first days of the second quarter—the S&P 500 dropped roughly 10% in the five trading periods through Apr. 7, 2025—investors with cash to spend might be looking

MarketBeat

Why DBV Technologies (DBVT) Stock Is Skyrocketing

DBV Technologies secured up to $306.9M to advance its Viaskin Peanut program. The funding supports FDA submission, commercialization and ongoing pediatric peanut allergy treatment research.

Henry Khederian

Dow Tumbles Over 500 Points; Abacus Global Management Shares Spike Higher

Avi Kapoor

Financials

Quarterly

Annual

Name

Revenue Change
Gross Change
EBITDA Change
EBIT Change
Earnings Change

Analyst Trends and Forecast

Oct 24

Dec 24

Jan

Mar

Buy

Hold

Sell

Strong Sell

Analyst Rating and Forecast

3.9

Buy

Strong Buy

Buy

Hold

Sell

Strong Sell

Open	$7.47
Close	$7.79
Volume / Avg.	52.59K / 407.44K
Day Range	$7.33 - $7.80
52 Wk Range	2.20 - 15.57
Market Cap	$201.75M
P/E Ratio	-
Dividend Yield	-
Exchange	NASDAQ
RSI	63
Short Interest	8.87%
Days to Cover	1

About DBV Technologies

Sector

Health Care

Industry

Biotechnology

DBV Technologies SA is a clinical-stage specialty biopharmaceutical company focused on changing the ...

Got Questions? Ask

What is DBVT's 200-day MA?

How is DBVT's EBITDA trending?

How is DBVT's revenue growing?

What is DBVT's operating cash flow?

What is DBVT's ROA?

Compare

EPS worse than industry

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

EPS worse than industry

FAQ

How do I buy DBV Technologies (DBVT) stock?

You can purchase shares of DBV Technologies (NASDAQ:DBVT) through any online brokerage.

View our list of the best stock brokerages

Who are DBV Technologies (DBVT) competitors?

Other companies in DBV Technologies’s space includes: Voyager Therapeutics (NASDAQ:VYGR), Monopar Therapeutics (NASDAQ:MNPR), Tevogen Bio Holdings (NASDAQ:TVGN), Anika Therapeutics (NASDAQ:ANIK) and Eledon Pharmaceuticals (NASDAQ:ELDN).

What is the forecast, or price target, for DBV Technologies (DBVT) stock?

DBV Technologies has a consensus price target of $7.00.

What is the current price for DBV Technologies (DBVT)?

The stock price for DBV Technologies (NASDAQ: DBVT) is $7.38 last updated April 14, 2025 at 4:19 PM EDT.

Does DBV Technologies (DBVT) pay a dividend?

There are no upcoming dividends for DBV Technologies.

When is DBV Technologies (NASDAQ:DBVT) reporting earnings?

DBV Technologies’s Q1 earnings are confirmed for Tuesday, May 6, 2025.

Is DBV Technologies (DBVT) going to split?

There is no upcoming split for DBV Technologies.

What sector and industry does DBV Technologies (DBVT) operate in?

DBV Technologies is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.

Comments

DBV Technologies Stock Price, Quotes and Forecasts

DBV Technologies (DBVT) Forecast